Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from DENTSPLY SIRONA ( (XRAY) ) is now available.
On December 24, 2025, Dentsply Sirona amended its revolving credit facility and several private note purchase agreements to reset key financial covenants and update leverage thresholds. The changes introduce stepped maximum total and senior leverage ratios through September 2027, tighten restrictions on restricted payments, cap EBITDA add-backs related to the company’s efficiency initiatives through year-end 2026, and exclude swap obligations from debt calculations, while adding interest rate adjustments tied to leverage levels. These moves are designed to help the company remain in material compliance with its debt covenants as it executes its cost-efficiency programs and manages its capital structure, potentially providing greater financial flexibility but also imposing stricter discipline on leverage and shareholder distributions.
The most recent analyst rating on (XRAY) stock is a Hold with a $12.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.
Spark’s Take on XRAY Stock
According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.
DENTSPLY SIRONA’s overall stock score is primarily impacted by its financial performance, which shows significant challenges across income, balance sheet, and cash flow statements. The technical analysis indicates bearish trends, and the valuation metrics are concerning with a negative P/E ratio. The earnings call sentiment is negative, highlighting strategic and operational difficulties. Despite a high dividend yield, the overall outlook remains cautious due to these pressing issues.
To see Spark’s full report on XRAY stock, click here.
More about DENTSPLY SIRONA
Dentsply Sirona Inc. operates in the dental equipment and consumables industry, providing a broad range of professional dental products, technologies and solutions used by dentists and dental laboratories worldwide, with a focus on clinical efficiency and digital dentistry.
Average Trading Volume: 3,606,288
Technical Sentiment Signal: Sell
Current Market Cap: $2.24B
For detailed information about XRAY stock, go to TipRanks’ Stock Analysis page.